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Abstract
In particular in the ‘meningitis belt’ of sub-Saharan Africa, epidemic meningococcal
meningitis is a severe public health problem. In the past decades, serogroup A
lineages have been the dominant etiologic agents, but also other serogroups have
caused outbreaks. A comprehensive vaccine based on subcapsular outer
membrane proteins (OMPs) is not available. Here, we have investigated whether
meningococcal populations overcome herd immunity by changing antigenic
properties of their OMPs. Meningococcal isolates were collected in the context
of longitudinal studies in Ghana between 2002 and 2008 and in Burkina Faso
between 2006 and 2007. Serogroup A strains isolated during two clonal waves of
colonization and disease showed no diversification in the genes encoding their
PorA, PorB, and FetA proteins. However, we detected occasional allelic exchange
of opa genes, as well as wide variation in the number of intragenic tandem repeats,
showing that phase variation of Opa protein expression is a frequent event.
Altogether we observed a remarkable antigenic stability of the PorA, PorB and
FetA proteins over years. Our results indicate that while herd immunity may be
responsible for the disappearance of meningococcal clones over time, it is not a
strong driving force for antigenic diversification of the major OMPs analyzed here.
Introduction
Neisseria meningitidis, a Gram-negative diplococcus, is an
obligate commensal of humans, usually carried in the upper
airways of healthy individuals. The bacterium is transmitted
to close contacts by the spread of respiratory secretions.
Occasionally, N. meningitidis strains might penetrate the
mucosal membrane, multiply in the bloodstream, and gain
access to the cerebrospinal fluid. The overall incidence rate
of meningococcal disease in Europe and North America is
1–3 per 100 000 person-years. The highest incidence
rates are found in countries of sub-Saharan Africa, in the
so-called ‘meningitis belt’, which extends from Ethiopia to
Senegal. In these countries, annual incidence rates of as
high as 1000 per 100 000 person-years are recorded during
the most severe epidemics (Caugant, 2008). The savannah
climate of the meningitis belt with an annual precipitation
index of 300–1100 mm and extremely dry and hot winter
seasons seems to be optimal for transmission of invasive
meningococcal disease. Epidemics classically occur in the
dry season, between December and April. They nearly
always start in the early part of the dry season and then stop
abruptly at the onset of rains. High temperature, low
absolute humidity and the harmattan (a dusty wind that
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blows from the Sahara) at the end of the dry season may
favor the occurrence of meningococcal disease by damag-
ing the local mucosal defenses (Greenwood, 1999).
Based on different capsular polysaccharide structures, 13
serogroups of N. meningitidis can be distinguished. The
vast majority of invasive meningococcal disease is caused
by six of these serogroups (A, B, C, W-135, X, and Y)
(Stephens et al., 2007). Most of the large epidemics in
Africa in the past 100 years were associated with serogroup
A (Caugant, 2008). Until recently, reactive immunization
campaigns with polysaccharide vaccines initiated after the
onset of meningitis epidemics have been used to limit
epidemics. Now a monovalent conjugate vaccine against
serogroup A meningococci, the most common cause of
large epidemics, is being introduced stepwise in the coun-
tries of the African meningitis belt. In contrast to the
unconjugated polysaccharides, conjugate vaccines will not
only protect the vaccinated from invasive disease, but are
also expected to block transmission of the meningococci
expressing the vaccine serogroup.
Lack of a stable nasopharyngeal population of apatho-
genic meningococci may contribute to the vulnerability of the
local population of the meningitis belt to major epidemics
(Leimkugel et al., 2007b). These are caused by hyperviru-
lent clones of N. meningitidis, which may travel through the
entire meningitis belt, but seem to remain only for a few
years associated with a particular population (Leimkugel
et al., 2007a, b). Herd immunity may lead to the disappear-
ance of individual clonal complexes, but new clones with a
different antigenic make-up may subsequently spread.
Clonal waves of colonization and disease are therefore a
characteristic feature of the epidemiology of meningococcal
meningitis in the African meningitis belt (Leimkugel et al.,
2007a, b). Neisseria meningitidis serogroup A strains of the
clonal complex 5 that are associated with the sequence
types (STs) 5, 7, and 2859 have been responsible for
outbreaks in the last two decades (Nicolas et al., 2005;
Teyssou & Muros-Le, 2007; Sie et al., 2008). Molecular
typing approaches based on DNA sequencing allow men-
ingococci to be distinguished and tracked (Jolley et al.,
2007). During the last decade, multi-locus sequence typing
(MLST) based on the identification of the alleles of
fragments of seven meningococcal housekeeping genes
has developed into the ‘gold standard’ for typing these
bacterial pathogens (Maiden et al., 1998; Brehony et al.,
2007).
Meningococci are naturally competent for transformation
by exogenous DNA, and high rates of recombination have
been observed (Jolley et al., 2005). However, most genetic
exchange appears to takes place between closely related
meningococci, and it has been suggested that recombina-
tion may be primarily a mechanism for genome repair that
will only occasionally result in generation of diversity
(Caugant & Maiden, 2009). Nevertheless, N. meningitidis
is genetically and antigenically highly diverse (http://pub
mlst.org/neisseria/). On the other hand, hyper-invasive
lineages seem to be surprisingly stable over decades and
during global spread (Caugant, 2008). This may facilitate
development of a comprehensive protein-based vaccine,
effective against a broad range of hyper-virulent meningo-
cocci. Cross-reactivity could be achieved by targeting
antigenically invariant subcapsular structures or by combin-
ing a cocktail of vaccine antigens selected on the basis of
molecular epidemiological studies. A number of meningo-
coccal surface structures are thought to play a role in
mucosal colonization, hematogenous spread and crossing
of the blood brain barrier (Hill et al., 2010). To escape
immune surveillance, meningococci have developed a
range of mechanisms to change surface components. We
assume that development of herd immunity is responsible
for the complete disappearance of meningococcal clones
after a few years of colonization of populations in the African
meningitis belt (Leimkugel et al., 2007a, b). Here we have
investigated whether meningococcal populations escape
from immune detection by varying their outer membrane
proteins (OMPs) PorA, PorB, FetA, and Opa. The serogroup
A ST7 and ST 2859 meningococci analyzed have been
collected between March 2002 and April 2008 in the course
of longitudinal meningococcal colonization and disease
surveys in Ghana and Burkina Faso (Leimkugel et al.,
2007a, b; Sie et al., 2008).
Materials and methods
Bacterial isolates
The N. meningitidis isolates investigated in this study had
been collected in the Kassena-Nankana District (KND) and
the neighboring district of Bawku in Ghana and in the Nouna
Health District (NHD) in the Kossi region of Burkina Faso.
Case strains were isolated from the cerebrospinal fluid of
meningitis patients, and carriage strains were isolated from
throat swabs collected in the context of longitudinal carriage
surveys. Isolation and characterization of strains has been
described previously (Gagneux, 2000; Leimkugel et al.,
2007a, b; Sie et al., 2008). For the analysis of genetic
diversification, serogroup A ST7 and ST2859 strains iso-
lated from cases and carriers at different times during clonal
colonization and disease waves were selected from our
strain collection. Included were nine ST7 carriage and seven
ST7 case isolates collected between March 2002 and March
2005 in the KND of Ghana. In the case of ST2859 strains,
we analyzed six case and seven carriage isolates collected
between March 2006 and March 2007 in the NHD of Burkina
Faso, three case and 15 carriage isolates from the KND, as
well as three case isolates collected between March 2007
and April 2008 in the neighboring district of Bawku.
Genetic analysis
DNA was extracted from bacterial pellets using the Wizard®
Genomic DNA Purification Kit (Promega AG, Duebendorf,
Switzerland). The DNA concentration was measured using a
Nano drop Spectrophotometer (Witec Ag, Littau, Switzer-
land). PCR was performed using 5 lL of 109 BD buffer and
1 lL of FirePol Taq polymerase, 1.25 mM MgCl2 (Solis
BioDyne, Tartu, Estonia), 100 ng of genomic DNA or the
equivalent volume of nuclease-free water as a negative
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control, a 0.2 lM concentration of each forward and reverse
primer, and a 0.2 mM concentration of each deoxynucleo-
side triphosphate in a total volume of 50 lL. PCRs were run
in a T Professional Basic PCR machine (Biometra GmbH,
Go¨ttingen, Germany). The thermal profile for PCR amplifi-
cation included an initial denaturation step of 94 °C for
2 min, followed by 35 cycles of 94 °C for 30 s, annealing at
55 °C for 30 s, and elongation at 72 °C for 1 min 20 s up to
2 min. ThePCRswere finalized by an extension step at 72 °C
for 10 min. PCR products were analyzed on 1% agarose
gels by gel electrophoresis using ethidium bromide staining
and the AlphaImager illuminator and AlphaImager software
(Alpha Innotech, San Leandro, CA). PCR products were
purified using a NucleoSpin purification kit (Macherey-Nagel
GmbH & Co. KG, Du¨ren, Germany) and subjected to direct
sequencing or cloned using a TOPO TA cloning kit (Invitro-
gen Corp., Carlsbad, CA), transformed into Novablue
competent cells (Merck, Darmstadt, Germany), and
sequenced after DNA preparation (Macherey-Nagel GmbH
& Co. KG, Du¨ren, Germany). Sequencing was performed by
Macrogen Inc, Seoul, Korea. For PorA, PorB, and FetA
typing, primers were used as previously described (Sacchi
et al., 1998; Thompson et al., 2003; Russell et al., 2004).
Primers used for amplification and sequencing of the opa
genes and their flanking regions are listed in Table 1.
Design of the primers used for amplification of opaA, opaB,
and opaD was based on the serogroup A strain Z2491
genome sequence (Parkhill et al., 2000) and the PRIMER3
program (http://frodo.wi.mit.edu/). The sequences obtained
were analyzed making use of the N. meningitidis homepage
(http://neisseria.org/nm/) and the Neisseria sequence typ-
ing homepage (http://pubmlst.org/neisseria/). The multiple
sequence alignment websites Multalin (http://bioinfo.genopole-
toulouse.prd.fr/multalin/multalin.html) and CLUSTALW2 (http://
www.ebi.ac.uk/Tools/clustalw2/index.html) were used for com-
parisons between Opa gene sequences and their flanking
regions. The EMBOSS TRANSEQ tool was used for the translation of
the retrieved opa gene sequences (http://www.ebi.ac.uk/Tools/
emboss/transeq/).
Results and discussion
Humans are the only natural host for N. meningitidis, and
nasopharyngeal carriage rates are known to be much higher
than disease rates. In a longitudinal study in the northern
Ghana, we have observed waves of colonization and
disease with hyper-virulent clones of serogroup A meningo-
cocci. About 4 years after their local emergence, these
clones disappeared completely (Leimkugel et al., 2007a, b).
This may be attributed to the development of herd immunity
against the colonizing clone in the local population. During
their spread from country to country, meningococcal clones
undergo microevolution with recombination as major driving
force for genetic variation (Achtman, 1995). As a conse-
quence, clones that, based on MLST, appear to be closely
related, may differ – due to multiple recombination events –
Table 1 Amplification and sequencing primers for opa genes and their flanking regions
OpaA Amplification primers VNTR15af TCATCCGCTACATTGTGTTGA
OpaA2r TCGTCATTCCCACGGAAGT
Sequencing primers VNTR15af TCATCCGCTACATTGTGTTGA
OpaA4r TTTCCTGATTTTCCGTCTTCA
OpaA5r ATGACGGTTCGGGTATTTCC
OpaA4f GCGGCAGATTATGCCAGTTA
OpaB Amplification primers OpaB2f CAGGACAAGGCGACGAG
OpaB5r TGTCTGGACGGGGATGT
Sequencing primers VNTR15br GCACACCGATATAGGGTTTGAA
OpaBf GTGTTGAAACATCGCCACAA
OpaBr1 GGCATTTTTCCATGCGTTT
OpaBff GCGAGAACTGAAGACGGAAA
OpaD Amplification primers OpaD5f TCTCCGTAGAGGAAATGATGC
OpaD3r AAGTGGGAATCTAGGACGTAAAA
Sequencing primers OpDf TCATCCGCTATATTGTGTTGA
Opa26f TGGGTCTTGGTGTCATCG
OpA26r GAATAATTACTTTCTTTCCATTTTCTG
OpD2f CGCCCCAAACCTGATATAGT
OpDr2 GAAACGGTGGGAATTGTGTAA
OpaJ Amplification primers Opaj5f CGCCCCAAACCTGATATAGT
Opaj1r ATCTAGAACGTGGGGTTTGG
Sequencing primers Opaj5f CGCCCCAAACCTGATATAGT
Opaj7f TGATATAGTCCGCTCCTGCAA
Opaj8f CGGTGCAGACAAAGACAAAA
Opaj9f GTCGCCGGTGCTGCTA
Opaj10r TAGCAGCACCGGCGAC
Opaj3r TTTGGGCAACTGTTTTTATCC
Pathogens and Disease (2013), 67, 4–10, © 2012 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved6
Neisseria meningitidis outer membrane protein microevolution C.A. Huber et al.
T
a
b
le
2
O
ri
g
in
a
n
d
c
h
a
ra
c
te
ri
s
ti
c
s
o
f
s
e
ro
g
ro
u
p
A
m
e
n
in
g
o
c
o
c
c
i
a
n
d
th
e
ir
O
M
P
s
a
n
a
ly
z
e
d
N
S
o
u
rc
e
O
ri
g
in
T
im
e
M
L
S
T
P
o
rA
P
o
rB
F
e
tA
O
p
a
A
O
p
a
B
O
p
a
D
O
p
a
J
S
T
A
lle
le
A
lle
le
A
lle
le
A
lle
le
R
e
p
e
a
ts
A
lle
le
R
e
p
e
a
ts
A
lle
le
R
e
p
e
a
ts
A
lle
le
R
e
p
e
a
ts
1
3
9
6
C
a
rr
ia
g
e
K
N
D
M
a
rc
h
2
0
0
2
7
2
0
,
9
3
-4
7
F
3
-1
2
4
2
1
4
2
5
3
1
2
2
9
6
9
2
1
3
7
1
5
7
7
C
a
rr
ia
g
e
K
N
D
M
a
rc
h
2
0
0
3
7
2
0
,
9
3
-4
7
F
3
-1
2
4
2
1
3
2
5
3
1
2
2
9
6
1
0
2
1
3
8
1
8
0
8
C
a
s
e
K
N
D
J
a
n
u
a
ry
2
0
0
4
7
2
0
,
9
3
-4
7
F
3
-1
2
4
2
9
2
5
3
8
2
9
6
1
2
2
1
3
8
1
8
1
3
C
a
s
e
K
N
D
F
e
b
ru
a
ry
2
0
0
4
7
2
0
,
9
3
-4
7
F
3
-1
2
4
2
9
2
5
3
8
2
9
6
1
2
2
1
3
8
1
8
1
2
C
a
s
e
K
N
D
F
e
b
ru
a
ry
2
0
0
4
7
2
0
,
9
3
-4
7
F
3
-1
2
4
2
1
0
2
5
3
9
2
9
6
1
0
2
1
3
9
1
8
2
2
C
a
s
e
K
N
D
F
e
b
ru
a
ry
2
0
0
4
7
2
0
,
9
3
-4
7
F
3
-1
2
4
2
1
4
2
5
3
1
2
2
9
6
1
0
2
1
3
9
1
8
3
8
C
a
s
e
K
N
D
M
a
rc
h
2
0
0
4
7
2
0
,
9
3
-4
7
F
3
-1
2
4
2
1
6
2
5
3
1
2
2
9
6
1
0
2
1
3
9
1
9
0
2
C
a
rr
ia
g
e
K
N
D
M
a
rc
h
2
0
0
4
7
2
0
,
9
3
-4
7
F
3
-1
2
4
2
1
4
2
5
3
1
1
2
9
6
9
2
1
3
9
1
9
9
0
C
a
rr
ia
g
e
K
N
D
M
a
rc
h
2
0
0
4
7
2
0
,
9
3
-4
7
F
3
-1
2
4
2
1
5
2
5
3
5
2
9
6
1
2
2
1
3
1
0
1
9
9
1
C
a
rr
ia
g
e
K
N
D
N
o
v
e
m
b
e
r
2
0
0
4
7
2
0
,
9
3
-4
7
F
3
-1
2
4
2
1
5
2
5
3
5
2
9
6
1
2
2
1
3
1
0
2
0
0
8
C
a
s
e
K
N
D
F
e
b
ru
a
ry
2
0
0
5
7
2
0
,
9
3
-4
7
F
3
-1
2
4
2
1
1
2
5
3
9
2
9
6
1
3
2
1
3
9
2
0
0
9
C
a
s
e
K
N
D
F
e
b
ru
a
ry
2
0
0
5
7
2
0
,
9
3
-4
7
F
3
-1
2
4
2
1
1
2
5
3
1
0
2
9
6
1
4
2
1
3
9
2
0
1
8
C
a
rr
ia
g
e
K
N
D
M
a
rc
h
2
0
0
5
7
2
0
,
9
3
-4
7
F
3
-1
2
4
2
8
2
5
3
8
2
9
6
1
0
2
1
3
9
2
0
1
9
C
a
rr
ia
g
e
K
N
D
M
a
rc
h
2
0
0
5
7
2
0
,
9
3
-4
7
F
3
-1
2
4
2
8
2
5
3
1
1
2
9
6
1
0
2
1
3
9
2
0
2
0
C
a
rr
ia
g
e
K
N
D
M
a
rc
h
2
0
0
5
7
2
0
,
9
3
-4
7
F
3
-1
2
4
2
1
1
2
5
3
8
2
9
6
1
3
2
1
3
9
2
0
2
1
C
a
rr
ia
g
e
K
N
D
M
a
rc
h
2
0
0
5
7
2
0
,
9
3
-4
7
F
3
-1
2
4
2
1
1
2
5
3
8
2
9
6
1
2
2
1
3
9
2
1
7
3
C
a
s
e
N
H
D
M
a
rc
h
2
0
0
6
2
8
5
9
2
0
,
9
3
-4
7
F
3
-1
2
4
2
8
2
5
3
8
2
9
6
1
0
1
2
7
1
2
2
1
7
1
C
a
s
e
N
H
D
M
a
rc
h
2
0
0
6
2
8
5
9
2
0
,
9
3
-4
7
F
3
-1
2
4
2
8
2
5
3
8
2
9
6
9
1
2
7
1
2
2
1
7
2
C
a
s
e
N
H
D
M
a
rc
h
2
0
0
6
2
8
5
9
2
0
,
9
3
-4
7
F
3
-1
2
4
2
8
2
5
3
8
2
9
6
9
1
2
7
1
2
2
1
7
4
C
a
s
e
N
H
D
M
a
rc
h
2
0
0
6
2
8
5
9
2
0
,
9
3
-4
7
F
3
-1
2
4
2
8
2
5
3
8
2
9
6
9
1
2
7
1
2
2
1
7
5
C
a
s
e
N
H
D
M
a
rc
h
2
0
0
6
2
8
5
9
2
0
,
9
3
-4
7
F
3
-1
2
4
2
8
2
5
3
8
2
9
6
9
1
2
7
1
2
2
1
7
6
C
a
s
e
N
H
D
M
a
rc
h
2
0
0
6
2
8
5
9
2
0
,
9
3
-4
7
F
3
-1
2
4
2
8
2
5
3
8
2
9
6
9
1
2
7
1
1
2
2
0
2
C
a
rr
ia
g
e
N
H
D
M
a
rc
h
2
0
0
6
2
8
5
9
2
0
,
9
3
-4
7
F
3
-1
2
4
2
9
2
5
3
8
2
9
6
1
0
1
2
7
1
3
2
2
4
3
C
a
rr
ia
g
e
N
H
D
M
a
rc
h
2
0
0
6
2
8
5
9
2
0
,
9
3
-4
7
F
3
-1
2
4
2
8
2
5
3
8
2
9
6
9
1
2
7
1
1
2
3
6
5
C
a
rr
ia
g
e
N
H
D
N
o
v
e
m
b
e
r
2
0
0
6
2
8
5
9
2
0
,
9
3
-4
7
F
3
-1
2
4
2
7
2
5
3
9
2
9
6
7
1
2
7
1
3
2
3
7
8
C
a
rr
ia
g
e
N
H
D
N
o
v
e
m
b
e
r
2
0
0
6
2
8
5
9
2
0
,
9
3
-4
7
F
3
-1
2
4
2
1
4
2
5
3
8
2
9
6
9
1
2
7
1
7
2
5
5
4
C
a
rr
ia
g
e
N
H
D
M
a
rc
h
2
0
0
7
2
8
5
9
2
0
,
9
3
-4
7
F
3
-1
2
4
2
1
0
2
5
3
1
1
2
9
6
9
1
2
7
9
2
5
6
0
C
a
rr
ia
g
e
N
H
D
M
a
rc
h
2
0
0
7
2
8
5
9
2
0
,
9
3
-4
7
F
3
-1
2
4
2
8
2
5
3
8
2
9
6
1
2
1
2
7
1
2
2
5
8
7
C
a
rr
ia
g
e
N
H
D
M
a
rc
h
2
0
0
7
2
8
5
9
2
0
,
9
3
-4
7
F
3
-1
2
4
2
8
2
5
3
8
2
9
6
1
2
1
2
7
8
2
5
3
7
C
a
s
e
B
a
w
k
u
M
a
rc
h
2
0
0
7
2
8
5
9
2
0
,
9
3
-4
7
F
3
-1
2
5
3
8
2
5
3
8
2
9
6
1
0
1
2
7
1
1
2
5
3
9
C
a
s
e
B
a
w
k
u
M
a
rc
h
2
0
0
7
2
8
5
9
2
0
,
9
3
-4
7
F
3
-1
2
5
3
8
2
5
3
8
2
9
6
1
0
1
2
7
1
2
2
5
4
1
C
a
s
e
B
a
w
k
u
M
a
rc
h
2
0
0
7
2
8
5
9
2
0
,
9
3
-4
7
F
3
-1
2
5
3
8
2
5
3
8
2
9
6
1
0
1
2
7
1
2
2
5
4
5
C
a
s
e
K
N
D
A
p
ri
l
2
0
0
7
2
8
5
9
2
0
,
9
3
-4
7
F
3
-1
2
5
3
8
2
5
3
8
2
9
6
1
0
1
2
7
1
2
2
5
0
2
C
a
rr
ia
g
e
K
N
D
A
p
ri
l
2
0
0
7
2
8
5
9
2
0
,
9
3
-4
7
F
3
-1
2
5
3
8
2
5
3
8
2
9
6
1
0
1
2
7
1
2
2
6
2
0
C
a
rr
ia
g
e
K
N
D
N
o
v
e
m
b
e
r
2
0
0
7
2
8
5
9
2
0
,
9
3
-4
7
F
3
-1
2
5
3
8
2
5
3
8
2
9
6
1
0
1
2
7
1
2
2
6
2
2
C
a
rr
ia
g
e
K
N
D
N
o
v
e
m
b
e
r
2
0
0
7
2
8
5
9
2
0
,
9
3
-4
7
F
3
-1
2
5
3
8
2
5
3
8
2
9
6
1
0
1
2
7
1
2
2
6
2
4
C
a
rr
ia
g
e
K
N
D
N
o
v
e
m
b
e
r
2
0
0
7
2
8
5
9
2
0
,
9
3
-4
7
F
3
-1
2
5
3
8
2
5
3
8
2
9
6
1
0
1
2
7
1
2
2
6
2
6
C
a
rr
ia
g
e
K
N
D
N
o
v
e
m
b
e
r
2
0
0
7
2
8
5
9
2
0
,
9
3
-4
7
F
3
-1
2
5
3
8
2
5
3
8
2
9
6
1
0
1
2
7
1
2
2
6
2
8
C
a
rr
ia
g
e
K
N
D
N
o
v
e
m
b
e
r
2
0
0
7
2
8
5
9
2
0
,
9
3
-4
7
F
3
-1
2
5
3
8
2
5
3
8
2
9
6
1
0
1
2
7
1
2
2
6
3
0
C
a
rr
ia
g
e
K
N
D
N
o
v
e
m
b
e
r
2
0
0
7
2
8
5
9
2
0
,
9
3
-4
7
F
3
-1
2
5
3
8
2
5
3
8
2
9
6
1
0
1
2
7
1
2
2
6
3
2
C
a
rr
ia
g
e
K
N
D
N
o
v
e
m
b
e
r
2
0
0
7
2
8
5
9
2
0
,
9
3
-4
7
F
3
-1
2
5
3
8
2
5
3
8
2
9
6
1
0
1
2
7
1
2
Pathogens and Disease (2013), 67, 4–10, © 2012 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved 7
C.A. Huber et al. Neisseria meningitidis outer membrane protein microevolution
very substantially in their antigenic profiles A. Lamelas and
G. Pluschke, Swiss Tropical and Public Health Institute.
Antibodies directed against OMPs have been implicated
in the development of natural immunity against meningo-
cocci. In particular, antibodies directed against the PorA and
PorB proteins seem to provide serosubtype-specific protec-
tion (Jordens et al., 2004). This prompted us to investigate
whether immune selection pressure building up in the
population during colonization waves leads to an antigenic
diversification of OMPs in the colonizing meningococcal
population.
The strains included in the sequence analysis of OMP-
encoding genes have been isolated from cerebrospinal fluid
(CSF) of meningitis patients or from the pharynx of healthy
carriers during two sequential colonization and disease
waves in northern Ghana and during a meningococcal
disease outbreak in Burkina Faso. Serogroup A ST7 strains
have been isolated from the start (2002) till the end (2005) of
a colonization wave in northern Ghana (Leimkugel et al.,
2007a, b). In the case of serogroup A ST 2859, isolates
from an outbreak in Burkina Faso (2006–2007) (Sie et al.,
2008) and in northern Ghana (2007–2008) were compared.
It has been proposed that the propensity of N. meningit-
idis to accumulate mutations increases dramatically toward
the end of an epidemic, presumably due to immune
pressure, and that with time, variants arise that are founders
of new clonal complexes (Achtman, 2004). However, in
none of the strains investigated here a single mutational
change in the genes encoding the surface proteins PorA,
PorB, or FetA was found. All PorA sequences had the VR1,
VR2: 20, 9 variable regions. The Por B sequences were
invariably of class 3 and had the allele 47. The variable
region of Fet A was F3-1. In spite of microevolution of the
epidemic clones, as detected by pulsed field gel electro-
phoresis (Leimkugel et al., 2007a, b), the sequence of the
analyzed OMP-encoding genes thus was strikingly stable.
No mutations were detected in the variable regions of the
surface proteins PorA, PorB, and FetA in any of the strains
analyzed. The benefit of accumulating mutations to escape
herd immunity may be dispossessed by the fitness cost that
such mutations confer (Achtman, 2004). Furthermore, the
lack of a genetically diverse pharyngeal flora of N. menin-
gitidis, in the study population (Leimkugel et al., 2007a, b),
limiting the extent of horizontal genetic exchange (Achtman,
1995) may contribute to this striking lack of diversification.
On the other hand, immune selection may act more strongly
on exposed antigens other than the major OMPs analyzed
here.
While the Ghanian meningococcal isolates analyzed here
have been collected over a longer period of time (between
2002 and 2008), conclusions on the stability of OMPs for the
strains from Burkina Faso are less strong, as the analyzed
strains were isolated over a period of only 2 years. Another
very important point to consider is that, although we did not
detect any diversification in the genes encoding PorA,
Por B, and FetA, expression levels of PorA and FetA are
subject to variation. Antibodies elicited against these
proteins in the host population may give selective advantage
to meningococcal strains with decreased expression levelsTa
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of PorA and FetA (Crowe et al., 1989; Carson et al., 2000).
PorB expression levels have been described to be constant,
however (Abad et al., 2006).
The multiple copies of genes encoding the Opa proteins
can be turned on and off during chromosomal replication by
slipped-strand mispairing of tandem CTTCT repeats present
in their open reading frames. Here, we have used the
published genome sequence of the serogroup A ST4 strain
Z2491 to design primers specific for the flanking regions of
the opaA, opaB, and opaD genes. In contrast to strain
Z2491, the ST7 and ST2859 strains analyzed here all
contained in addition an opaJ gene, as has been described
for other ST5-complex/subgroup III strains (Callaghan et al.,
2006). While all PorA, PorB, and FetA had the same alleles
irrespective of the time point and location of isolation as well
as the ST of the strains examined (Table 2), two of the four
opa genes analyzed were subject to some variation. While
all the ST7 strains from Ghana and the ST2859 strains from
Burkina Faso had the opaA allele 242, all Ghanaian ST2859
strains had the allele 253. No variation was observed within
the three individual groups of epidemiologically related
isolates. ST7 and ST2859 are MLST single-locus variants,
and the ST2859 genocloud may have developed from ST7
meningococci in Africa. The change in the opaA allele in the
ST 2859 strains that emerged in Ghana in 2008 may have
been due to homologous recombination and immune
selection against the 242 allele (Callaghan et al., 2008;
Levin & Cornejo, 2009). In the case of the opaJ gene, all
ST7 isolates had the allele 213, whereas the ST2859 strains
both from Ghana and from Burkina Faso had the allele 127.
The numbers of pentanucleotide repeats within the coding
sequences of the opa genes were subject to much wider
variation. However, strains isolated at the same location and
a similar time point tended to be relatively uniform. For
example, all Ghanaian ST2859 isolates from 2007 had 8
opaA, 8 opaB, and 10 opaD repeats, while 5/6 isolates from
2008 had 10 opaA, 7 opaB, and 12 opaD repeats. This
variation in numbers of tandem repeats is due to slipped-
strand mispairing and results in phase variation involving on/
off expression of the respective opa gene (Murphy et al.,
1989). Alleles with a number of pentanucleotide repeats are
a multiple of three represent functional genes (Table 2).
Antigenic variation in the Opa genes has been suggested to
mediate immune evasion (Davidsen & Tonjum, 2006;
Callaghan et al., 2008). Functional open reading frames
were found for all four opa genes, but no more than two
functional opa genes were found in any of the strains. A
Poisson regression analysis was performed (http://www.
fisherstat.com/Pages/default.aspx), and disease and colo-
nization isolates did not differ significantly in the Opa protein
expression patterns (Table 2). While the invasive bacteria
may represent rare genetic variants of the colonizing
meningococcal population, a change in the Opa protein
expression pattern thus does not seem to be relevant for an
adaptation for multiplication in the blood stream and the
CSF.
Control ofmeningitis epidemics has relied so far on reactive
vaccination strategies with polysaccharide vaccines, and a
serogroup A conjugate vaccine is currently being introduced
in the meningitis belt. In our study, we have observed an
apparent lack of diversification of PorA, PorB, and FetA, and
a tailor-made vaccine targeting those OMPs may be able to
control the epidemic strains investigated. However, to
develop a comprehensive vaccine based on subcapsular
OMPs, whole-genome analyses of epidemiologically well-
defined isolate collections may be needed. Comparative
genomics may give insight into the driving forces behind the
microevolution of N. meningitidis, allowing a more compre-
hensive analysis of antigen variability, as well as the
identification of new vaccine targets. Results of such
analyses may thus help identifying antigens suitable for
inclusion into a multivalent protein subunit vaccine (Tan
et al., 2010).
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